We are live on
!
Find out more
Immunic
IMUX
IMUX
24 hedge funds and large institutions have $15M invested in Immunic in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 24 → 24 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.05% less ownership
Funds ownership: 1.54% → 1.49% (-0.05%)
15% less capital invested
Capital invested by funds: $17.6M → $15M (-$2.63M)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
4
Reduced
8
Closed
5
Calls
$2.77M
Puts
–
Net Calls
+$2.77M
Net Calls Change
-$1.57M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$379K |
| 2 |
BlackRock
New York
|
+$169K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$151K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$23.2K |
| 5 |
JP Morgan Chase
New York
|
+$17.1K |
